Abstract
The fact was presented in this paper that there was no quantitative parallelism between the tumor-growth retarding effect of a compound on animal tumors and its inhibiting effect on dehydrogenase activity in vitro of the living cells of the same kind of tumor. An attention should therefore be paid to this fact when a drug is to be selected for clinical purpose from the anti-cancer agents by comparing their inhibiting activity on this enzyme of tumor piece taken from a patient.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
